229 related articles for article (PubMed ID: 20583735)
1. Bioactive glass S53P4 in the filling of cavities in the mastoid cell area in surgery for chronic otitis media.
Stoor P; Pulkkinen J; Grénman R
Ann Otol Rhinol Laryngol; 2010 Jun; 119(6):377-82. PubMed ID: 20583735
[TBL] [Abstract][Full Text] [Related]
2. Bioactive glass S53P4 in mastoid obliteration surgery for chronic otitis media and cerebrospinal fluid leakage.
Sarin J; Grénman R; Aitasalo K; Pulkkinen J
Ann Otol Rhinol Laryngol; 2012 Sep; 121(9):563-9. PubMed ID: 23012893
[TBL] [Abstract][Full Text] [Related]
3. A technique for concurrent procedure of mastoid obliteration and meatoplasty after canal wall down mastoidectomy.
Kim CW; Oh JI; Choi KY; Park SM; Park MI
Auris Nasus Larynx; 2012 Dec; 39(6):557-61. PubMed ID: 22321811
[TBL] [Abstract][Full Text] [Related]
4. Mastoid obliteration with S53P4 bioactive glass after canal wall down mastoidectomy: Preliminary results.
Król B; Cywka KB; Skarżyńska MB; Skarżyński PH
Am J Otolaryngol; 2021; 42(2):102895. PubMed ID: 33429176
[TBL] [Abstract][Full Text] [Related]
5. Postauricular periosteal-pericranial flap for mastoid obliteration and canal wall down tympanomastoidectomy.
Ramsey MJ; Merchant SN; McKenna MJ
Otol Neurotol; 2004 Nov; 25(6):873-8. PubMed ID: 15547414
[TBL] [Abstract][Full Text] [Related]
6. Bioactive glass obliteration of the mastoid significantly improves surgical outcome in non-cholesteatomatous chronic otitis media patients.
Vos J; de Vey Mestdagh P; Colnot D; Borggreven P; Orelio C; Quak J
Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4121-4126. PubMed ID: 28956143
[TBL] [Abstract][Full Text] [Related]
7. [Use of bone pate and bioactive glass granules for mastoid obliteration in cholesteatoma surgery].
Gerlinger I; Szabó É; Szanyi I; Rostás T; Pap I; Révész P; Kopjár E
Orv Hetil; 2022 May; 163(21):838-845. PubMed ID: 35598213
[TBL] [Abstract][Full Text] [Related]
8. Tolerance and safety of 45S5 bioactive glass used in obliteration procedures during middle ear surgery: Preliminary results.
Al Tamami N; Bawazeer N; Fieux M; Zaouche S; Tringali S
Am J Otolaryngol; 2020; 41(6):102542. PubMed ID: 32620365
[TBL] [Abstract][Full Text] [Related]
9. Mastoidectomy cavity obliteration with bioactive glass: a pilot study.
Silvola JT
Otolaryngol Head Neck Surg; 2012 Jul; 147(1):119-26. PubMed ID: 22371341
[TBL] [Abstract][Full Text] [Related]
10. Bioactive glass (S53P4) as obliteration material in subtotal petrosectomy: initial experience.
Lindeboom JJ; Colnot DR; Buwalda J
J Laryngol Otol; 2023 Jan; 137(1):105-107. PubMed ID: 35535475
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative findings of revision canal wall-down tympanomastoid surgery.
Kasenõmm P
Acta Otolaryngol; 2013 Aug; 133(8):826-32. PubMed ID: 23848263
[TBL] [Abstract][Full Text] [Related]
12. Canal wall down tympanomastoidectomy: the 'on-disease' approach for retraction pockets and cholesteatoma.
Grewal DS; Hathiram BT; Saraiya SV
J Laryngol Otol; 2007 Sep; 121(9):832-9. PubMed ID: 17295937
[TBL] [Abstract][Full Text] [Related]
13. Single flap with three pedicles, bone paté and split-thickness skin graft for immediate mastoid obliteration after canal wall down mastoidectomy.
Mokbel KM; Khafagy YW
Eur Arch Otorhinolaryngol; 2012 Sep; 269(9):2037-41. PubMed ID: 22127570
[TBL] [Abstract][Full Text] [Related]
14. Canal wall reconstruction tympanomastoidectomy with mastoid obliteration.
Gantz BJ; Wilkinson EP; Hansen MR
Laryngoscope; 2005 Oct; 115(10):1734-40. PubMed ID: 16222186
[TBL] [Abstract][Full Text] [Related]
15. [Long-term results following mastoid obliteration in canal wall down tympanomastoidectomy].
Beutner D; Stumpf R; Zahnert T; Hüttenbrink KB
Laryngorhinootologie; 2007 Dec; 86(12):861-6. PubMed ID: 17724623
[TBL] [Abstract][Full Text] [Related]
16. Repair of iatrogenic temporal lobe encephalocele after canal wall down mastoidectomy in the presence of active cholesteatoma.
McMurphy AB; Oghalai JS
Otol Neurotol; 2005 Jul; 26(4):587-94. PubMed ID: 16015151
[TBL] [Abstract][Full Text] [Related]
17. [Obliteration of mastoid cavities: 30 years of experience with recommendations for surgical strategy].
Schimanski G; Schimanski E
HNO; 2015 Aug; 63(8):538-45. PubMed ID: 26219522
[TBL] [Abstract][Full Text] [Related]
18. Prospective cohort comparison of bioactive glass implants and conchal cartilage in reconstruction of the posterior canal wall during tympanomastoidectomy.
Abramovich S; Hannan SA; Huins CT; Georgalas C; McGuinness J; Vats A; Thompson I
Clin Otolaryngol; 2008 Dec; 33(6):553-9. PubMed ID: 19126129
[TBL] [Abstract][Full Text] [Related]
19. Autologous bone pate in middle ear and mastoid reconstruction.
Roche P; Coolahan I; Glynn F; Mc Conn WR
Rev Laryngol Otol Rhinol (Bord); 2011; 132(4-5):193-6. PubMed ID: 22908539
[TBL] [Abstract][Full Text] [Related]
20. Mastoid Obliteration with Synthetic Materials: A Review of the Literature.
Skoulakis C; Koltsidopoulos P; Iyer A; Kontorinis G
J Int Adv Otol; 2019 Dec; 15(3):400-404. PubMed ID: 31846919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
